VitalStone Financial’s Arcadia Biosciences RKDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1
Closed – – 566
2024
Q1
$0 Hold
1
– – ﹤0.01% 586
2023
Q4
$0 Hold
1
– – ﹤0.01% 573
2023
Q3
$0 Hold
1
– – ﹤0.01% 595
2023
Q2
$0 Buy
+1
New +$5 ﹤0.01% 1026
2023
Q1
– Hold
0
– – – 484
2022
Q4
– Hold
0
– – – 578

Other funds holding RKDA

VitalStone Financial's RKDA Position: Q2 2024 in Review

VitalStone Financial sold out of Arcadia Biosciences (RKDA) in Q2 2024, closing a stake of 1 share.

VitalStone Financial first reported a position in RKDA in Q2 2023 and held it in 4 quarters. The position peaked at $0 in Q1 2024. 11 funds tracked by Wall St. Rank hold RKDA as of Q2 2024.

  • VitalStone Financial reported no remaining Arcadia Biosciences position as of Q2 2024 after selling out during the quarter.
  • VitalStone Financial sold 1 Arcadia Biosciences share in Q2 2024.
  • VitalStone Financial first reported a position in Arcadia Biosciences in Q2 2023 and held it in 4 quarters.
  • VitalStone Financial's Arcadia Biosciences position peaked at $0 in Q1 2024.
  • 11 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2024.

Based on VitalStone Financial's 13F filing for Q2 2024, filed 7 Aug 2024.